Public health impacts of foodborne mycotoxins

Annual Review of Food Science and Technology

Volumn 5, Issue 1, 2014, Pages 351-372

  Wu, Felicia ^a   Groopman, John D ^b   Pestka, James J ^a  

^a Michigan State University   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aflatoxins; Fumonisins; Human disease; Interventions; Ochratoxin A; Trichothecenes

Indexed keywords

FUMONISINS; HUMAN DISEASE; INTERVENTIONS; OCHRATOXIN A; TRICHOTHECENES;

AFLATOXINS; CROPS; DISEASES; FUNGI;

TOXICITY;

AFLATOXIN; FUMONISIN; MYCOTOXIN; OCHRATOXIN; TRICHOTHECENE DERIVATIVE;

ANIMAL; CHEMICALLY INDUCED DISORDER; CHILD; COST OF ILLNESS; CROP; DIET; ESOPHAGUS TUMOR; FOOD CONTAMINATION; FOOD POISONING; GASTROENTERITIS; GROWTH DISORDER; HUMAN; IMMUNOPATHOLOGY; LIVER TUMOR; MICROBIOLOGY; NEURAL TUBE DEFECT; NEWBORN; PUBLIC HEALTH; REVIEW;

AFLATOXINS; ANIMALS; CHILD; COST OF ILLNESS; CROPS, AGRICULTURAL; DIET; ESOPHAGEAL NEOPLASMS; FOOD CONTAMINATION; FOODBORNE DISEASES; FUMONISINS; GASTROENTERITIS; GROWTH DISORDERS; HUMANS; IMMUNE SYSTEM DISEASES; INFANT, NEWBORN; LIVER NEOPLASMS; MYCOTOXINS; NEURAL TUBE DEFECTS; OCHRATOXINS; PUBLIC HEALTH; TRICHOTHECENES;

EID: 84897732768     PISSN: 19411413     EISSN: 19411421     Source Type: Journal    
DOI: 10.1146/annurev-food-030713-092431     Document Type: Article

References (307)

1. Abdulrazzaq YM, Osman N, Yousif ZM, Trad O. 2004. Morbidity in neonates of mothers who have ingested aflatoxins. Ann. Trop. Paediatr. 24:145-51
2. Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P. 1994. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317-19
3. Allander E. 1994. Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand. J. Rheumatol. Suppl. 99:1-36
4. Asao T, Buchi G, Abdel-KaderM, Chang S, Wick E, Wogan GN. 1963. Aflatoxins b and g. J. Am. Chem. Soc. 85:1706-7
5. Autrup H, Bradley KA, Shamsuddin AK, Wakhisi J, Wasunna A. 1983. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis 4:1193-95
6. Autrup H, Seremet T, Wakhisi J, Wasunna A. 1987. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res. 47:3430-33
7. Azziz-Baumgartner E, Lindblade K, Gieseker K, Rogers HS, Kieszak S, et al. 2005. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health Perspect. 113:1779-83
8. Beardall JM, Miller JD. 1994. Diseases in humans with mycotoxins as possible causes. SeeMiller & Trenholm 1994, pp. 487-569
9. Bergsjo B, Langseth W, Nafstad I, Jansen JH, Larsen HJ. 1993. The effects of naturally deoxynivalenolcontaminated oats on the clinical condition, blood parameters, performance and carcass composition of growing pigs. VetResCommun 17:283-94
10. Bergsjo B, Matre T, Nafstad I. 1992. Effects of diets with graded levels of deoxynivalenol on performance in growing pigs. Zent. Vet. A 39:752-58
11. Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. 1989. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet 1:35-37
12. Bhat RV, Krishnamachari KA. 1977. Follow-up study of aflatoxic hepatitis in parts of western India. Indian J. Med. Res. 66:55-58
13. Blount WP. 1961. Turkey "x" disease. J. Br. Turkey Fed. 9:52-54
14. Bondy GS, Pestka JJ. 2000. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3(2):109-43
15. Bressac B, Kew M, Wands J, Ozturk M. 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-31
16. Bui-Klimke T, Wu F. 2014. Ochratoxin A and human health risk: A review of the evidence. Crit. Rev. Food Sci. Nutr. In press
17. Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA. 1982. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int. J. Epidemiol. 11:112-19
18. Campbell TC, Caedo JP Jr, Bulatao-Jayme J, Salamat L, Engel RW. 1970. Aflatoxin m1 in human urine. Nature 227:403-4
19. Canady RA, Coker RD, Rgan SK, Krska R, Kuiper-Goodman T, et al. 2001. Deoxynivalenol. In Safety Evaluation of Certain Mycotoxins in Food, ed. JECFA, pp. 420-555. Geneva: Int. Progr. Chem. Saf., World Health Org. 56th Rep
20. CDC. 2004. Outbreak of aflatoxin poisoning-eastern and central provinces, Kenya, January-July 2004. MMWR Morb. Mortal. Wkly. Rep. 53:790-93
21. Chen J-G, Egner PA, Ng D, Jacobson LP, Mu ? noz A, et al. 2013. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev. Res. 6:1038-45
22. Chen J-G, Zhu J, Parkin DM, Zhang YH, Lu JH, et al. 2006a. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int. J. Cancer 119:1447-54
23. Chen JH, Chu YL, Cao JL, Yang ZT, Guo X, Wang ZL. 2006b. T-2 toxin induces apoptosis, and selenium partly blocks, T-2 toxin induced apoptosis in chondrocytes through modulation of the Bax/Bcl-2 ratio. Food Chem. Toxicol. 44:567-73
24. Chen JH, Xue S, Li S, Wang ZL, Yang H, et al. 2012. Oxidant damage in Kashin-Beck disease and a rat Kashin-Beck disease model by employing T-2 toxin treatment under selenium deficient conditions. J. Orthop. Res. 30:1229-37
25. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C 1994. Chinese herbs nephropathy: A clue to Balkan endemic nephropathy? Kidney Int. 45(6):1680-88
26. Czakai K, Muller K, Mosesso P, Pepe G, Schulze M, et al. 2011. Perturbation of mitosis through inhibition of histone acetyltransferases: The key to ochratoxin A toxicity and carcinogenicity? Toxicol. Sci. 122(2):317-29
27. Eriksen GS, Alexander J, eds. 1998. Fusarium Toxins in Cereals-A Risk Assessment. Copenhagen, Den.: Nordic Counc. Minist
28. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893-917
29. Fukui Y, Hoshino K, Kameyama Y, Yasui T, Toda C, Nagano H. 1987. Placental transfer of ochratoxin A and its cytotoxic effect on the mouse embryonic brain. Food Chem. Toxicol. 25(1):17-24
30. Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, et al. 1988. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: Correlation with aflatoxin B1 intake and urinary excretion of aflatoxin m1. Carcinogenesis 9:1323-25
31. Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG. 1991. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12:1247-51
32. Gelineau-van Waes J, Starr L, Maddox J, Aleman F, Voss KA, et al. 2005. Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model. Birth Defects Res. A Clin. Mol. Teratol. 73:487-97
33. Gilbert J, Brereton P, MacDonald S. 2001. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 18:1088-93
34. Gong Y, Hounsa A, Egal S, Turner PC, Sutcliffe AE, et al. 2004. Postweaning exposure to aflatoxin results in impaired child growth: A longitudinal study in Benin, West Africa. Environ. Health Perspect. 112:1334-38
35. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, et al. 2002. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: Cross sectional study. BMJ 325:20-21
36. Gouze ME, Laffitte J, Pinton P, Dedieux G, Galinier A, et al. 2007. Effect of subacute oral doses of nivalenol on immune and metabolic defence systems in mice. Vet. Res. 38:635-46
37. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-78
38. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, et al. 2007. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 104(29):12129-34
39. Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN. 1985. Aflatoxin metabolism in humans: Detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA 82:6492-96
40. Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, et al. 1992a. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in the Gambia, West Africa. Cancer Epidemiol. Biomarkers Prev. 1:221-27
41. Groopman JD, Kensler TW, Wild CP. 2008. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public Health 29:187-203
42. Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, et al. 1992b. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi autonomous region, People's Republic of China. Cancer Res. 52:45-52
43. Guan F, Li S, Wang ZL, Yang H, Xue S, et al. 2013. Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin-Beck disease using T-2 toxin and selenium deficiency conditions. Rheumatol. Int. 33:157-66
44. Hagelberg S, Hult K, Fuchs R. 1989. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9(2):91-96
45. Henry SH, Bosch FX, Troxell TC, Bolger PM. 1999. Reducing liver cancer-global control of aflatoxin. Science 286:2453-54
46. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-28
47. Hughes DM, Gahl MJ, Graham CH, Grieb SL. 1999. Overt signs of toxicity to dogs and cats of dietary deoxynivalenol. J. Anim. Sci. 77:693-700
48. IARC. 1972. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 1, Some Inorganic Substances, Chlorinated Hydrocarbons, Aromatic Amines, N-Nitroso Compounds, and Natural Products: Summary of Data Reported and Evaluation. Lyron, Fr. WHO
49. IARC. 1993. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 56. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, Fr.: WHO
50. Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, et al. 1995. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog. Carcinog. Mutagen. 15:283-306
51. Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, et al. 2001. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res. 61:33-35
52. Jackson PE, Kuang SY, Wang JB, Strickland PT, Munoz A, et al 2003. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 24:1657-63
53. JECFA. 1998. Safety Evaluation of Certain Food Additives and Contaminants: WHO Food Additive Series 40. Geneva:WHO
54. JECFA. 2002. Evaluation of certain mycotoxins in food: 56th report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 906:42-51
55. JECFA. 2011a. Evaluation of certain contaminants in food: 72nd report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 959:37-48
56. JECFA. 2011b. Evaluation of certain food additives and contaminants: 74th report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 966:1-125
57. Jiang Y, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH. 2005. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 17:807-14
58. Joffe AZ. 1978. Fusarium poae and F. sporotichiodes as principal causal agents of alimentary toxic aleukia. In Mycotoxic Fungi, Mycotoxins, Mycotoxicoses: An Encylcopedic Handbook, ed. TD Wyllie, LGMorehouse, pp. 21-86. New York: Dekker
59. Kabak B, Dobson ADW, Var I. 2006. Strategies to prevent mycotoxin contamination of food and animal feed: A review. Crit. Rev. Food Sci. Nutr. 46:593-619
60. Kang P, Yao Y, Yang J, Shen B, Zhou Z, Pei F. 2013. An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin. Osteoarthr. Cartil. 21:1108-15
61. Khlangwiset P, Wu F. 2010. Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit. Contam. 27:998-1014
62. Khlangwiset P, Shephard GS, Wu F. 2011. Aflatoxins and growth impairment: A review. Crit. Rev. Toxicol. 41:740-55
63. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, et al. 2000. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia. J. Natl. Cancer Inst. 92:148-53
64. Krishnamachari KA, Bhat RV, Nagarajan V, Tilak TB. 1975. Hepatitis due to aflatoxicosis. an outbreak in western India. Lancet 1:1061-63
65. Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, et al. 1974. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A-contaminated feed. Acta Pathol.Microbiol. Scand. Suppl. 1994(246):1-21
66. Kubosaki A, Aihara M, Park BJ, Sugiura Y, Shibutani M, et al. 2008. Immunotoxicity of nivalenol after subchronic dietary exposure to rats. Food Chem. Toxicol. 46:253-58
67. Kuiper-Goodman T. 1994. Prevention of humanmycotoxicoses through risk assessment and riskmanagement. In Mycotoxins in Grain, ed. JD Miller, HL Trenholm, pp. 439-69. St. Paul, MN: Eagan
68. Lancaster MC, Jenkins FP, Philp JM. 1961. Toxicity associated with certain samples of groundnuts. Nature 192:1095-96
69. Lewis L, Onsongo M, Njapau H, Schurz-Rogers H, Luber G, et al. 2005. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environ. Health Perspect. 113:1763-67
70. Li FQ, Li YW, Luo XY, Yoshizawa T. 2002. Fusarium toxins in wheat from an area in Henan Province, PR China, with a previous human red mould intoxication episode. Food Addit. Contam. 19:163-67
71. Li SY, Cao JL, Shi ZL, Chen JH, Zhang ZT, et al. 2008. Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. J. Zhejiang Univ. Sci. B 9:22-33
72. Liu Y, Chang CC, Marsh GM, Wu F. 2012. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-Analysis. Eur. J. Cancer 48:2125-36
73. Liu Y, Wu F. 2010. Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ. Health Perspect. 118:818-24
74. Lu M, Cao J, Liu F, Li S, Chen J, et al. 2012. The effects of mycotoxins and selenium deficiency on tissueengineered cartilage. Cells Tissues Organs 196:241-50
75. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, et al. 1997. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57:3471-77
76. Luo X. 1994. Food poisoning caused by Fusarium toxins In Proceedings of the Second Asian Conference on Food Safety, ed. ILSI, pp. 129-36. Thailand: Text J. Publ. Co., Ltd
77. Lye MS, Ghazali AA, Mohan J, Alwin N, Nair RC. 1995. An outbreak of acute hepatic encephalopathy due to severe aflatoxicosis in Malaysia. Am. J. Trop. Med. Hyg. 53:68-72
78. Mahdavi R, Nikniaz L, Arefhosseini SR, Vahed Jabbari M. 2010. Determination of aflatoxinM1 in breast milk samples in Tabriz-Iran. Matern. Child Health J. 14:141-45
79. Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel PG, van der Lugt JJ. 1988. Leukoencephalomalacia in a horse induced by fumonisin B1, isolated from Fusarium moniliforme. Onderstepoort J. Vet. Res. 55:197-203
80. Marasas WFO, Riley RT, Hendricks KA, Stevens VL, Sadler TW, et al. 2006. Exposure to fumonisins and the occurrence of neural tube defects along theTexas-Mexico border. Environ.Health Perspect. 114(2):237-41
81. Miller JD, Trenholm HL, eds. 1994. Mycotoxins in Grain: Compounds Other than Aflatoxin. St. Paul, MN: Eagan
82. Missmer SA, Cabrera J, Torres O, Gelderblom WCA, Allegood J, et al. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutrition 134:711-16
83. Nascimento J, Nunes VA, Guedes RMC, Rachid MA. 2001. T-2 toxin and disturbed endochondral bone growth in broiler chicken. Arquivo Brasileiro Med. Vet. Zootecnia 53:332-40
84. National Toxicology Program (NTP). 1989. Toxicology and carcinogenesis studies of ochratoxin A (CASNo. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358:1-142
85. Nejdfors P, Ekelund M, Jeppsson B, Westrom BR. 2000. Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: Species-And region-related differences. Scand. J. Gastroenterol. 35:501-7
86. Nesbitt BF, O'Kelly J, Sargeant K, Sheridan A. 1962. Aspergillus flavus and turkey x disease. Toxic metabolites of Aspergillus flavus. Nature 195:1062-63
87. Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, et al. 1982. Outbreak of acute hepatitis caused by aflatoxin poisoning in kenya. Lancet 1:1346-48
88. Ohtsubo K, Ryu JC, Nakamura K, Izumiyama N, Tanaka T, et al. 1989. Chronic toxicity of nivalenol in female mice: A 2-year feeding study with Fusarium nivale Fn 2B-moulded rice. Food Chem. Toxicol. 27:591-98
89. Okoth SA, Ohingo M. 2004. Dietary aflatoxin exposure and impaired growth in young children from Kisumu District, Kenya: Cross sectional study. Afr. J. Health Sci. 11:43-54
90. Osweiler GD, Ross PF, Wilson TM, Nelson PE, Witte ST, et al. 1992. Characterization of an epizootic of pulmonary edema in swine associated with fumonisin in corn screenings. J. Vet. Diagn. Investig. 4:53-59
91. Ozturk M. 1991. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356-59
92. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108
93. Peers FG, Linsell CA. 1977. Dietary aflatoxins and human primary liver cancer. Ann. Nutr. Aliment. 31:1005-17
94. Pestka JJ. 2010a. Deoxynivalenol-induced proinflammatory gene expression: Mechanisms and pathological sequelae. Toxins (Basel) 2:1300-17
95. Pestka JJ. 2010b. Toxicological mechanisms and potential health effects of deoxynivalenol and nivalenol. World Mycotoxin J. 3:323-47
96. Pestka JJ, Lin WS, Miller ER. 1987. Emetic activity of the trichothecene 15-Acetyldeoxynivalenol in swine. Food Chem. Toxicol.: Int. J. Published Br. Ind. Biol. Res. Assoc. 25:855-58
97. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: Toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 8:39-69
98. Pfohl-Leszkowicz A, Manderville RA. 2007. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51(1):61-99
99. Pieters MN, Freijer J, Baars BJ, Fiolet DC, van Klaveren J, Slob W. 2002. Risk assessment of deoxynivalenol in food: Concentration limits, exposure and effects. Adv. Exp. Med. Biol. 504:235-48
100. Probst C, Njapau H, Cotty PJ. 2007. Outbreak of an acute aflatoxicosis in Kenya in 2004: Identification of the causal agent. Appl. Environ. Microbiol. 73:2762-64
101. Pronk M, Schothorst R, Egmond Hv. 2002. Toxicology and occurrence of nivalenol, fusarenon X, diacetoxyscirpenol, neosolaniol and 3-And 15-Acetyldeoxynivalenol; a review of six trichothecenes. RIVM Rep. 388802024, Natl. Inst. Public Health Environ, Bilthoven, Neth. http://www.rivm.nl/en/ Documents-And-publications/ Scientific/Reports/2002/november/Toxicology-And- occurrence-of-nivalenol-fusarenon-X-diacetoxyscirpenol-neosolaniol-And-3-And-15- Acetyldeoxynivalenol-A-review-of-six-trichothecenes?sp= cml2bXE9ZmFsc2U7c2VhcmNoYmFzZT01MTk3MDtyaXZtcT1mYWxz ZTs=&pagenr=5198
102. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, et al. 1994. A follow-up-study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3:3-10
103. Ricci K, Girosi F, Tarr P, Lim Y, Mason C, et al. 2006. Reducing stunting among children: The potential contribution of diagnostics. Nature 444:29-38
104. Ringot D, Chango A, Schneider YJ, Larondelle Y. 2006. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159(1):18-46
105. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, et al. 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943-46
106. Rotter BA, Thompson BK, Prelusky DB, Trenholm HL, Stewart B, Miller JD, Savard ME. 1996. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: Growth and clinical parameters. Nat. Toxins 4:42-50
107. Ryu J-C, Ohtsubo K, Izumiyama N, Nakamura K, Tanaka T, et al. 1988. The acute and chronic toxicities of nivalenol in mice. Fundam. Appl. Toxicol. 11:38-47
108. Sadeghi N, Oveisi M, Jannat B, Hajimahmoodi M, Bonyani H, Jannat F. 2009. Incidence of aflatoxin M 1 in human breast milk in Tehran, Iran. Food Control 20:75-78
109. Sargeant K, Sheridan A, O'Kelly J, Carnaghan RBA. 1961. Toxicity associated with certain samples of groundnuts. Nature 192:1096-97
110. SCF. 2002. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. SCF Rep. SCF/CS/CNTM/MYC/27, Eur. Comm., Brussels, Belg. http://ec.europa.eu/food/fs/sc/scf/out123-en.pdf
111. Shank RC, Bourgeois CH, Keschamras N, Chandavimol P. 1971. Aflatoxins in autopsy specimens from Thai children with an acute disease of unknown aetiology. Food Cosmet Toxicol. 9:501-7
112. Shephard G, Marasas W, Burger H, Somdyala N, Rheeder J, Van der Westhuizen L, et al. 2007. Exposure assessment for fumonisins in the former Transkei region of SouthAfrica. Food Addit. Contam. 24(6):621-29
113. Shephard GS, Marasas WF, Yazdanpanah H, Rahimian H, Safavi N, et al. 2002. Fumonisin B1 in maize harvested in Iran during 1999. Food Addit. Contam. 19(7):676-79
114. Shuaib FM, Jolly PE, Ehiri JE, Yatich N, Jiang Y, et al. 2010. Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop. Med. Int. Health 15:160-67
115. Sidransky D, Hollstein M. 1996. Clinical implications of the p53 gene. Annu. Rev. Med. 47:285-301
116. Starkey DE, Ward TJ, Aoki T, Gale LR, Kistler HC, et al. 2007. Global molecular surveillance reveals novel Fusarium head blight species and trichothecene toxin diversity. Fungal Genet. Biol. 44:1191-204
117. Steinberg EB, Henderson A, Karpati A, Hoekstra M, Marano N, et al. 2006. Mysterious outbreaks of gastrointestinal illness associated with burritos supplied through school lunch programs. J. Food Protect. 69:1690-98
118. Strosnider H, Azziz-Baumgartner E, Banziger M, Bhat RV, Breiman R, et al. 2006. Workgroup report: Public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect. 114:1898-903
119. Studer-Rohr I, Schlatter J, Dietrich DR. 2000. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch. Toxicol. 74(9):499-510
120. Sugita-Konishi Y, Nakajiima T. 2010. Nivalenol: The mycology, occurrence, toxicology, analysis and regulation. In Mycotoxins in Food, Feed and Bioweapons, ed. MV Rai, A Varma, pp. 253-73. Berlin/Heidelberg: Springer-Verlag
121. Sun G, Wang S, Hu X, Su J, Huang T, et al. 2007. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit. Contam. 24(2):181-85
122. Sun G, Wang S, Hu X, Su J, Zhang Y, et al. 2011. Co-contamination of aflatoxin B(1) and fumonisin B(1) in food and human dietary exposure in three areas of China. Food Addit. Contam. A Chem. Anal. Control Expo. Risk Assess. 18:1-10
123. Sun LY, Li Q, Meng FG, Fu Y, Zhao ZJ, Wang LH. 2012. T-2 toxin contamination in grains and selenium concentration in drinking water and grains in Kaschin-Beck disease endemic areas of Qinghai Province. Biol. Trace Elem. Res. 150:371-75
124. SunZ, Lu P, GailMH, Pee D, ZhangQ, et al 1999. Increased risk of hepatocellular carcinoma inmale hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.Hepatology 30:379-83
125. Sydenham EW, Marasas WFO, Shephard GS, Thiel PG, Hirooka EY. 1992. Fumonisin concentrations in Brazilian feeds associated with field outbreaks of confirmed and suspected animal mycotoxicoses. J. Agric. Food Chem. 40:994-97
126. Szelenyi I, Herold H, Gothert M. 1994. Emesis induced in domestic pigs: A new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents. J. Pharmacol. Toxicol. Methods 32:109-16
127. Takahashi M, Shibutani M, Sugita-Konishi Y, Aihara M, Inoue K, et al. 2008. A 90-day subchronic toxicity study of nivalenol, a trichothecene mycotoxin, in F344 rats. Food Chem. Toxicol. 46:125-35
128. Turesky RJ. 2005. Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 18(7):1082-90
129. Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP. 2003. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111:217-20
130. Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, et al. 2007. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 36:1119-25
131. Turner PC, Flannery B, Isitt C, Ali M, Pestka J. 2012. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr. Res. Rev. 25:162-79
132. Van der Zijden AS, Blanche Koelensmid WA, Boldingh J, Barrett CB, Ord WO, Philp J. 1962. Isolation in crystalline form of a toxin responsible for turkey x disease. Nature 195:1060-62
133. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF. 1985. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 51:713-26
134. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, et al. 1995. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol. Biomarkers Prev. 4:475-83
135. Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, et al. 1998. Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum. Exp. Toxicol. 17:124-29
136. Wang LY, Hatch M, Chen CJ, Levin B, You SL, et al. 1996. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67:620-25
137. Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, et al. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182:43-47
138. Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, et al. 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in the Gambia, west Africa. Cancer Epidemiol. Biomarkers Prev. 1:229-34
139. Wogan GN, Kensler TW, Groopman JD. 2012. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 29:249-57
140. Wogan GN, Newberne PM. 1967. Dose-response characteristics of aflatoxin b1 carcinogenesis in the rat. Cancer Res. 27:2370-76
141. Wu F. 2013. Aflatoxin exposure and chronic human diseases: Estimates of burden of disease. In Aflatoxins: Finding Solutions for Improved Food Safety, ed. L Unnevehr, D Grace, Focus 20, Brief 3.Washington, DC: Int. Food Policy Res. Inst. http://www.ifpri.org/sites/default/files/publications/focus20.pdf
142. Wu F, Munkvold GP. 2008. Mycotoxins in ethanol co-products: Modeling economic impacts on the livestock industry. J. Agric. Food Chem. 56:3900-11
143. Wu F, Khlangwiset P. 2010. Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa. Food Addit. Contam. 27:658-76
144. Wu F, Stacy SL, Kensler TW. 2013. Global risk assessment of aflatoxins in maize and peanuts: Are regulatory standards adequately protectivé Toxicol. Sci. 135:251-59
145. Wu W, Bates MA, Bursian SJ, Flannery B, Zhou HR, et al. 2013a. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). Toxicol. Sci. 133:186-95
146. Wu W, Bates MA, Bursian SJ, Link JE, Flannery BM, et al. 2013b. Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-Acetyldeoxynivalenol, 3-Acetyldeoxynivalenol, fusarenon X, and nivalenol. Toxicol. Sci. 131:279-91
147. Yan D, Kang P, Li Y, Yang J, Shen B, et al. 2011. Radiographic findings of Wistar rats fed with T-2 toxin and Kashin-Beck disease-Affected diet. Int. J. Rheum. Dis. 14:92-97
148. Yan D, Kang P, Yang J, Shen B, Zhou Z, et al 2010. The effect of Kashin-Beck disease-Affected feed and T-2 toxin on the bone development of Wistar rats. Int. J. Rheum. Dis. 13:266-72
149. Yeh FC, Chang CL, Liu WS. 1986. Anesthesia management in malnutritional patients. Ma Zui Xue Za Zhi 24:216-21
150. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. 1989. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:2506-9
151. Yoshizawa T. 1983. Trichothecenes-Chemical, Biological, and Toxicological Aspects (Developments in Food Science), ed. Y Ueno, pp. 195-209. Tokyo, Japan: Kodansha Ltd
152. Young LG, McGirr L, Valli VE, Lumsden JH, Lun A. 1983. Vomitoxin in corn fed to young pigs. J. Anim. Sci. 57:655-64
153. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. 1997. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol. 27:320-30
154. Zhai SS, Kimbrough RD, Meng B, Han JY, LeVois M, et al. 1990. Kashin-Beck disease: A cross-sectional study in seven villages in the People's Republic of China. J. Toxicol. Environ. Health 30:239-59
155. Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P. 1994. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317-19
156. Allander E. 1994. Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand. J. Rheumatol. Suppl. 99:1-36
157. Asao T, Buchi G, Abdel-KaderM, Chang S, Wick E, Wogan GN. 1963. Aflatoxins b and g. J. Am. Chem. Soc. 85:1706-7
158. Autrup H, Bradley KA, Shamsuddin AK, Wakhisi J, Wasunna A. 1983. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis 4:1193-95
159. Autrup H, Seremet T, Wakhisi J, Wasunna A. 1987. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res. 47:3430-33
160. Azziz-Baumgartner E, Lindblade K, Gieseker K, Rogers HS, Kieszak S, et al. 2005. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health Perspect. 113:1779-83
161. Beardall JM, Miller JD. 1994. Diseases in humans with mycotoxins as possible causes. SeeMiller & Trenholm 1994, pp. 487-569
162. Bergsjo B, Langseth W, Nafstad I, Jansen JH, Larsen HJ. 1993. The effects of naturally deoxynivalenolcontaminated oats on the clinical condition, blood parameters, performance and carcass composition of growing pigs. VetResCommun 17:283-94
163. Bergsjo B, Matre T, Nafstad I. 1992. Effects of diets with graded levels of deoxynivalenol on performance in growing pigs. Zent. Vet. A 39:752-58
164. Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. 1989. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet 1:35-37
165. Bhat RV, Krishnamachari KA. 1977. Follow-up study of aflatoxic hepatitis in parts of western India. Indian J. Med. Res. 66:55-58
166. Blount WP. 1961. Turkey "x" disease. J. Br. Turkey Fed. 9:52-54
167. Bondy GS, Pestka JJ. 2000. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3(2):109-43
168. Bressac B, Kew M, Wands J, Ozturk M. 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-31
169. Bui-Klimke T, Wu F. 2014. Ochratoxin A and human health risk: A review of the evidence. Crit. Rev. Food Sci. Nutr. In press
170. Bulatao-Jayme J, Almero EM, Castro MC, Jardeleza MT, Salamat LA. 1982. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int. J. Epidemiol. 11:112-19
171. Campbell TC, Caedo JP Jr, Bulatao-Jayme J, Salamat L, Engel RW. 1970. Aflatoxin m1 in human urine. Nature 227:403-4
172. Canady RA, Coker RD, Rgan SK, Krska R, Kuiper-Goodman T, et al. 2001. Deoxynivalenol. In Safety Evaluation of Certain Mycotoxins in Food, ed. JECFA, pp. 420-555. Geneva: Int. Progr. Chem. Saf., World Health Org. 56th Rep
173. CDC. 2004. Outbreak of aflatoxin poisoning-eastern and central provinces, Kenya, January-July 2004. MMWR Morb. Mortal. Wkly. Rep. 53:790-93
174. Chen J-G, Egner PA, Ng D, Jacobson LP, Mu ? noz A, et al. 2013. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev. Res. 6:1038-45
175. Chen J-G, Zhu J, Parkin DM, Zhang YH, Lu JH, et al. 2006a. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int. J. Cancer 119:1447-54
176. Chen JH, Chu YL, Cao JL, Yang ZT, Guo X, Wang ZL. 2006b. T-2 toxin induces apoptosis, and selenium partly blocks, T-2 toxin induced apoptosis in chondrocytes through modulation of the Bax/Bcl-2 ratio. Food Chem. Toxicol. 44:567-73
177. Chen JH, Xue S, Li S, Wang ZL, Yang H, et al. 2012. Oxidant damage in Kashin-Beck disease and a rat Kashin-Beck disease model by employing T-2 toxin treatment under selenium deficient conditions. J. Orthop. Res. 30:1229-37
178. Cosyns JP, Jadoul M, Squifflet JP, De Plaen JF, Ferluga D, van Ypersele de Strihou C 1994. Chinese herbs nephropathy: A clue to Balkan endemic nephropathy? Kidney Int. 45(6):1680-88
179. Czakai K, Muller K, Mosesso P, Pepe G, Schulze M, et al. 2011. Perturbation of mitosis through inhibition of histone acetyltransferases: The key to ochratoxin A toxicity and carcinogenicity? Toxicol. Sci. 122(2):317-29
180. Eriksen GS, Alexander J, eds. 1998. Fusarium Toxins in Cereals-A Risk Assessment. Copenhagen, Den.: Nordic Counc. Minist
181. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893-917
182. Fukui Y, Hoshino K, Kameyama Y, Yasui T, Toda C, Nagano H. 1987. Placental transfer of ochratoxin A and its cytotoxic effect on the mouse embryonic brain. Food Chem. Toxicol. 25(1):17-24
183. Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, et al. 1988. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: Correlation with aflatoxin B1 intake and urinary excretion of aflatoxin m1. Carcinogenesis 9:1323-25
184. Gelderblom WCA, Kriek NPJ, Marasas WFO, Thiel PG. 1991. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12:1247-51
185. Gelineau-van Waes J, Starr L, Maddox J, Aleman F, Voss KA, et al. 2005. Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model. Birth Defects Res. A Clin. Mol. Teratol. 73:487-97
186. Gilbert J, Brereton P, MacDonald S. 2001. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 18:1088-93
187. Gong Y, Hounsa A, Egal S, Turner PC, Sutcliffe AE, et al. 2004. Postweaning exposure to aflatoxin results in impaired child growth: A longitudinal study in Benin, West Africa. Environ. Health Perspect. 112:1334-38
188. Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, et al. 2002. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: Cross sectional study. BMJ 325:20-21
189. Gouze ME, Laffitte J, Pinton P, Dedieux G, Galinier A, et al. 2007. Effect of subacute oral doses of nivalenol on immune and metabolic defence systems in mice. Vet. Res. 38:635-46
190. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-78
191. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, et al. 2007. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 104(29):12129-34
192. Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN. 1985. Aflatoxin metabolism in humans: Detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA 82:6492-96
193. Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, et al. 1992a. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in the Gambia, West Africa. Cancer Epidemiol. Biomarkers Prev. 1:221-27
194. Groopman JD, Kensler TW, Wild CP. 2008. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public Health 29:187-203
195. Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, et al. 1992b. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi autonomous region, People's Republic of China. Cancer Res. 52:45-52
196. Guan F, Li S, Wang ZL, Yang H, Xue S, et al. 2013. Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin-Beck disease using T-2 toxin and selenium deficiency conditions. Rheumatol. Int. 33:157-66
197. Hagelberg S, Hult K, Fuchs R. 1989. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9(2):91-96
198. Henry SH, Bosch FX, Troxell TC, Bolger PM. 1999. Reducing liver cancer-global control of aflatoxin. Science 286:2453-54
199. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-28
200. Hughes DM, Gahl MJ, Graham CH, Grieb SL. 1999. Overt signs of toxicity to dogs and cats of dietary deoxynivalenol. J. Anim. Sci. 77:693-700
201. IARC. 1972. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 1, Some Inorganic Substances, Chlorinated Hydrocarbons, Aromatic Amines, N-Nitroso Compounds, and Natural Products: Summary of Data Reported and Evaluation. Lyron, Fr. WHO
202. IARC. 1993. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 56. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, Fr.: WHO
203. Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, et al. 1995. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog. Carcinog. Mutagen. 15:283-306
204. Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, et al. 2001. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res. 61:33-35
205. Jackson PE, Kuang SY, Wang JB, Strickland PT, Munoz A, et al 2003. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 24:1657-63
206. JECFA. 1998. Safety Evaluation of Certain Food Additives and Contaminants: WHO Food Additive Series 40. Geneva:WHO
207. JECFA. 2002. Evaluation of certain mycotoxins in food: 56th report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 906:42-51
208. JECFA. 2011a. Evaluation of certain contaminants in food: 72nd report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 959:37-48
209. JECFA. 2011b. Evaluation of certain food additives and contaminants: 74th report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Tech. Rep. Ser. 966:1-125
210. Jiang Y, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH. 2005. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 17:807-14
211. Joffe AZ. 1978. Fusarium poae and F. sporotichiodes as principal causal agents of alimentary toxic aleukia. In Mycotoxic Fungi, Mycotoxins, Mycotoxicoses: An Encylcopedic Handbook, ed. TD Wyllie, LGMorehouse, pp. 21-86. New York: Dekker
212. Kabak B, Dobson ADW, Var I. 2006. Strategies to prevent mycotoxin contamination of food and animal feed: A review. Crit. Rev. Food Sci. Nutr. 46:593-619
213. Kang P, Yao Y, Yang J, Shen B, Zhou Z, Pei F. 2013. An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin. Osteoarthr. Cartil. 21:1108-15
214. Khlangwiset P, Wu F. 2010. Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit. Contam. 27:998-1014
215. Khlangwiset P, Shephard GS, Wu F. 2011. Aflatoxins and growth impairment: A review. Crit. Rev. Toxicol. 41:740-55
216. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, et al. 2000. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia. J. Natl. Cancer Inst. 92:148-53
217. Krishnamachari KA, Bhat RV, Nagarajan V, Tilak TB. 1975. Hepatitis due to aflatoxicosis. an outbreak in western India. Lancet 1:1061-63
218. Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, et al. 1974. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A-contaminated feed. Acta Pathol.Microbiol. Scand. Suppl. 1994(246):1-21
219. Kubosaki A, Aihara M, Park BJ, Sugiura Y, Shibutani M, et al. 2008. Immunotoxicity of nivalenol after subchronic dietary exposure to rats. Food Chem. Toxicol. 46:253-58
220. Kuiper-Goodman T. 1994. Prevention of humanmycotoxicoses through risk assessment and riskmanagement. In Mycotoxins in Grain, ed. JD Miller, HL Trenholm, pp. 439-69. St. Paul, MN: Eagan
221. Lancaster MC, Jenkins FP, Philp JM. 1961. Toxicity associated with certain samples of groundnuts. Nature 192:1095-96
222. Lewis L, Onsongo M, Njapau H, Schurz-Rogers H, Luber G, et al. 2005. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central Kenya. Environ. Health Perspect. 113:1763-67
223. Li FQ, Li YW, Luo XY, Yoshizawa T. 2002. Fusarium toxins in wheat from an area in Henan Province, PR China, with a previous human red mould intoxication episode. Food Addit. Contam. 19:163-67
224. Li SY, Cao JL, Shi ZL, Chen JH, Zhang ZT, et al. 2008. Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. J. Zhejiang Univ. Sci. B 9:22-33
225. Liu Y, Chang CC, Marsh GM, Wu F. 2012. Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-Analysis. Eur. J. Cancer 48:2125-36
226. Liu Y, Wu F. 2010. Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ. Health Perspect. 118:818-24
227. Lu M, Cao J, Liu F, Li S, Chen J, et al. 2012. The effects of mycotoxins and selenium deficiency on tissueengineered cartilage. Cells Tissues Organs 196:241-50
228. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, et al. 1997. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 57:3471-77
229. Luo X. 1994. Food poisoning caused by Fusarium toxins In Proceedings of the Second Asian Conference on Food Safety, ed. ILSI, pp. 129-36. Thailand: Text J. Publ. Co., Ltd
230. Lye MS, Ghazali AA, Mohan J, Alwin N, Nair RC. 1995. An outbreak of acute hepatic encephalopathy due to severe aflatoxicosis in Malaysia. Am. J. Trop. Med. Hyg. 53:68-72
231. Mahdavi R, Nikniaz L, Arefhosseini SR, Vahed Jabbari M. 2010. Determination of aflatoxinM1 in breast milk samples in Tabriz-Iran. Matern. Child Health J. 14:141-45
232. Marasas WFO, Kellerman TS, Gelderblom WCA, Coetzer JAW, Thiel PG, van der Lugt JJ. 1988. Leukoencephalomalacia in a horse induced by fumonisin B1, isolated from Fusarium moniliforme. Onderstepoort J. Vet. Res. 55:197-203
233. Marasas WFO, Riley RT, Hendricks KA, Stevens VL, Sadler TW, et al. 2006. Exposure to fumonisins and the occurrence of neural tube defects along theTexas-Mexico border. Environ.Health Perspect. 114(2):237-41
234. Miller JD, Trenholm HL, eds. 1994. Mycotoxins in Grain: Compounds Other than Aflatoxin. St. Paul, MN: Eagan
235. Missmer SA, Cabrera J, Torres O, Gelderblom WCA, Allegood J, et al. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: A potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutrition 134:711-16
236. Nascimento J, Nunes VA, Guedes RMC, Rachid MA. 2001. T-2 toxin and disturbed endochondral bone growth in broiler chicken. Arquivo Brasileiro Med. Vet. Zootecnia 53:332-40
237. National Toxicology Program (NTP). 1989. Toxicology and carcinogenesis studies of ochratoxin A (CASNo. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358:1-142
238. Nejdfors P, Ekelund M, Jeppsson B, Westrom BR. 2000. Mucosal in vitro permeability in the intestinal tract of the pig, the rat, and man: Species-And region-related differences. Scand. J. Gastroenterol. 35:501-7
239. Nesbitt BF, O'Kelly J, Sargeant K, Sheridan A. 1962. Aspergillus flavus and turkey x disease. Toxic metabolites of Aspergillus flavus. Nature 195:1062-63
240. Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, et al. 1982. Outbreak of acute hepatitis caused by aflatoxin poisoning in kenya. Lancet 1:1346-48
241. Ohtsubo K, Ryu JC, Nakamura K, Izumiyama N, Tanaka T, et al. 1989. Chronic toxicity of nivalenol in female mice: A 2-year feeding study with Fusarium nivale Fn 2B-moulded rice. Food Chem. Toxicol. 27:591-98
242. Okoth SA, Ohingo M. 2004. Dietary aflatoxin exposure and impaired growth in young children from Kisumu District, Kenya: Cross sectional study. Afr. J. Health Sci. 11:43-54
243. Osweiler GD, Ross PF, Wilson TM, Nelson PE, Witte ST, et al. 1992. Characterization of an epizootic of pulmonary edema in swine associated with fumonisin in corn screenings. J. Vet. Diagn. Investig. 4:53-59
244. Ozturk M. 1991. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356-59
245. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108
246. Peers FG, Linsell CA. 1977. Dietary aflatoxins and human primary liver cancer. Ann. Nutr. Aliment. 31:1005-17
247. Pestka JJ. 2010a. Deoxynivalenol-induced proinflammatory gene expression: Mechanisms and pathological sequelae. Toxins (Basel) 2:1300-17
248. Pestka JJ. 2010b. Toxicological mechanisms and potential health effects of deoxynivalenol and nivalenol. World Mycotoxin J. 3:323-47
249. Pestka JJ, Lin WS, Miller ER. 1987. Emetic activity of the trichothecene 15-Acetyldeoxynivalenol in swine. Food Chem. Toxicol.: Int. J. Published Br. Ind. Biol. Res. Assoc. 25:855-58
250. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: Toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 8:39-69
251. Pfohl-Leszkowicz A, Manderville RA. 2007. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51(1):61-99
252. Pieters MN, Freijer J, Baars BJ, Fiolet DC, van Klaveren J, Slob W. 2002. Risk assessment of deoxynivalenol in food: Concentration limits, exposure and effects. Adv. Exp. Med. Biol. 504:235-48
253. Probst C, Njapau H, Cotty PJ. 2007. Outbreak of an acute aflatoxicosis in Kenya in 2004: Identification of the causal agent. Appl. Environ. Microbiol. 73:2762-64
254. Pronk M, Schothorst R, Egmond Hv. 2002. Toxicology and occurrence of nivalenol, fusarenon X, diacetoxyscirpenol, neosolaniol and 3-And 15-Acetyldeoxynivalenol; a review of six trichothecenes. RIVM Rep. 388802024, Natl. Inst. Public Health Environ, Bilthoven, Neth. http://www.rivm.nl/en/ Documents-And-publications/ Scientific/Reports/2002/november/Toxicology-And- occurrence-of-nivalenol-fusarenon-X-diacetoxyscirpenol-neosolaniol-And-3-And-15- Acetyldeoxynivalenol-A-review-of-six-trichothecenes?sp= cml2bXE9ZmFsc2U7c2VhcmNoYmFzZT01MTk3MDtyaXZtcT1mYWxz ZTs=&pagenr=5198
255. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, et al. 1994. A follow-up-study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3:3-10
256. Ricci K, Girosi F, Tarr P, Lim Y, Mason C, et al. 2006. Reducing stunting among children: The potential contribution of diagnostics. Nature 444:29-38
257. Ringot D, Chango A, Schneider YJ, Larondelle Y. 2006. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159(1):18-46
258. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, et al. 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339:943-46
259. Rotter BA, Thompson BK, Prelusky DB, Trenholm HL, Stewart B, Miller JD, Savard ME. 1996. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: Growth and clinical parameters. Nat. Toxins 4:42-50
260. Ryu J-C, Ohtsubo K, Izumiyama N, Nakamura K, Tanaka T, et al. 1988. The acute and chronic toxicities of nivalenol in mice. Fundam. Appl. Toxicol. 11:38-47
261. Sadeghi N, Oveisi M, Jannat B, Hajimahmoodi M, Bonyani H, Jannat F. 2009. Incidence of aflatoxin M 1 in human breast milk in Tehran, Iran. Food Control 20:75-78
262. Sargeant K, Sheridan A, O'Kelly J, Carnaghan RBA. 1961. Toxicity associated with certain samples of groundnuts. Nature 192:1096-97
263. SCF. 2002. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. SCF Rep. SCF/CS/CNTM/MYC/27, Eur. Comm., Brussels, Belg. http://ec.europa.eu/food/fs/sc/scf/out123-en.pdf
264. Shank RC, Bourgeois CH, Keschamras N, Chandavimol P. 1971. Aflatoxins in autopsy specimens from Thai children with an acute disease of unknown aetiology. Food Cosmet Toxicol. 9:501-7
265. Shephard G, Marasas W, Burger H, Somdyala N, Rheeder J, Van der Westhuizen L, et al. 2007. Exposure assessment for fumonisins in the former Transkei region of SouthAfrica. Food Addit. Contam. 24(6):621-29
266. Shephard GS, Marasas WF, Yazdanpanah H, Rahimian H, Safavi N, et al. 2002. Fumonisin B1 in maize harvested in Iran during 1999. Food Addit. Contam. 19(7):676-79
267. Shuaib FM, Jolly PE, Ehiri JE, Yatich N, Jiang Y, et al. 2010. Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop. Med. Int. Health 15:160-67
268. Sidransky D, Hollstein M. 1996. Clinical implications of the p53 gene. Annu. Rev. Med. 47:285-301
269. Starkey DE, Ward TJ, Aoki T, Gale LR, Kistler HC, et al. 2007. Global molecular surveillance reveals novel Fusarium head blight species and trichothecene toxin diversity. Fungal Genet. Biol. 44:1191-204
270. Steinberg EB, Henderson A, Karpati A, Hoekstra M, Marano N, et al. 2006. Mysterious outbreaks of gastrointestinal illness associated with burritos supplied through school lunch programs. J. Food Protect. 69:1690-98
271. Strosnider H, Azziz-Baumgartner E, Banziger M, Bhat RV, Breiman R, et al. 2006. Workgroup report: Public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect. 114:1898-903
272. Studer-Rohr I, Schlatter J, Dietrich DR. 2000. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch. Toxicol. 74(9):499-510
273. Sugita-Konishi Y, Nakajiima T. 2010. Nivalenol: The mycology, occurrence, toxicology, analysis and regulation. In Mycotoxins in Food, Feed and Bioweapons, ed. MV Rai, A Varma, pp. 253-73. Berlin/Heidelberg: Springer-Verlag
274. Sun G, Wang S, Hu X, Su J, Huang T, et al. 2007. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit. Contam. 24(2):181-85
275. Sun G, Wang S, Hu X, Su J, Zhang Y, et al. 2011. Co-contamination of aflatoxin B(1) and fumonisin B(1) in food and human dietary exposure in three areas of China. Food Addit. Contam. A Chem. Anal. Control Expo. Risk Assess. 18:1-10
276. Sun LY, Li Q, Meng FG, Fu Y, Zhao ZJ, Wang LH. 2012. T-2 toxin contamination in grains and selenium concentration in drinking water and grains in Kaschin-Beck disease endemic areas of Qinghai Province. Biol. Trace Elem. Res. 150:371-75
277. SunZ, Lu P, GailMH, Pee D, ZhangQ, et al 1999. Increased risk of hepatocellular carcinoma inmale hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.Hepatology 30:379-83
278. Sydenham EW, Marasas WFO, Shephard GS, Thiel PG, Hirooka EY. 1992. Fumonisin concentrations in Brazilian feeds associated with field outbreaks of confirmed and suspected animal mycotoxicoses. J. Agric. Food Chem. 40:994-97
279. Szelenyi I, Herold H, Gothert M. 1994. Emesis induced in domestic pigs: A new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents. J. Pharmacol. Toxicol. Methods 32:109-16
280. Takahashi M, Shibutani M, Sugita-Konishi Y, Aihara M, Inoue K, et al. 2008. A 90-day subchronic toxicity study of nivalenol, a trichothecene mycotoxin, in F344 rats. Food Chem. Toxicol. 46:125-35
281. Turesky RJ. 2005. Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 18(7):1082-90
282. Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP. 2003. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111:217-20
283. Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, et al. 2007. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 36:1119-25
284. Turner PC, Flannery B, Isitt C, Ali M, Pestka J. 2012. The role of biomarkers in evaluating human health concerns from fungal contaminants in food. Nutr. Res. Rev. 25:162-79
285. Van der Zijden AS, Blanche Koelensmid WA, Boldingh J, Barrett CB, Ord WO, Philp J. 1962. Isolation in crystalline form of a toxin responsible for turkey x disease. Nature 195:1060-62
286. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF. 1985. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 51:713-26
287. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, et al. 1995. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol. Biomarkers Prev. 4:475-83
288. Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, et al. 1998. Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum. Exp. Toxicol. 17:124-29
289. Wang LY, Hatch M, Chen CJ, Levin B, You SL, et al. 1996. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 67:620-25
290. Wang XW, Hussain SP, Huo TI, Wu CG, Forgues M, et al. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182:43-47
291. Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, et al. 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in the Gambia, west Africa. Cancer Epidemiol. Biomarkers Prev. 1:229-34
292. Wogan GN, Kensler TW, Groopman JD. 2012. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 29:249-57
293. Wogan GN, Newberne PM. 1967. Dose-response characteristics of aflatoxin b1 carcinogenesis in the rat. Cancer Res. 27:2370-76
294. Wu F. 2013. Aflatoxin exposure and chronic human diseases: Estimates of burden of disease. In Aflatoxins: Finding Solutions for Improved Food Safety, ed. L Unnevehr, D Grace, Focus 20, Brief 3.Washington, DC: Int. Food Policy Res. Inst. http://www.ifpri.org/sites/default/files/publications/focus20.pdf
295. Wu F, Munkvold GP. 2008. Mycotoxins in ethanol co-products: Modeling economic impacts on the livestock industry. J. Agric. Food Chem. 56:3900-11
296. Wu F, Khlangwiset P. 2010. Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa. Food Addit. Contam. 27:658-76
297. Wu F, Stacy SL, Kensler TW. 2013. Global risk assessment of aflatoxins in maize and peanuts: Are regulatory standards adequately protectivé Toxicol. Sci. 135:251-59
298. Wu W, Bates MA, Bursian SJ, Flannery B, Zhou HR, et al. 2013a. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin). Toxicol. Sci. 133:186-95
299. Wu W, Bates MA, Bursian SJ, Link JE, Flannery BM, et al. 2013b. Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-Acetyldeoxynivalenol, 3-Acetyldeoxynivalenol, fusarenon X, and nivalenol. Toxicol. Sci. 131:279-91
300. Yan D, Kang P, Li Y, Yang J, Shen B, et al. 2011. Radiographic findings of Wistar rats fed with T-2 toxin and Kashin-Beck disease-Affected diet. Int. J. Rheum. Dis. 14:92-97
301. Yan D, Kang P, Yang J, Shen B, Zhou Z, et al 2010. The effect of Kashin-Beck disease-Affected feed and T-2 toxin on the bone development of Wistar rats. Int. J. Rheum. Dis. 13:266-72
302. Yeh FC, Chang CL, Liu WS. 1986. Anesthesia management in malnutritional patients. Ma Zui Xue Za Zhi 24:216-21
303. Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ, Henderson BE. 1989. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49:2506-9
304. Yoshizawa T. 1983. Trichothecenes-Chemical, Biological, and Toxicological Aspects (Developments in Food Science), ed. Y Ueno, pp. 195-209. Tokyo, Japan: Kodansha Ltd
305. Young LG, McGirr L, Valli VE, Lumsden JH, Lun A. 1983. Vomitoxin in corn fed to young pigs. J. Anim. Sci. 57:655-64
306. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. 1997. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol. 27:320-30
307. Zhai SS, Kimbrough RD, Meng B, Han JY, LeVois M, et al. 1990. Kashin-Beck disease: A cross-sectional study in seven villages in the People's Republic of China. J. Toxicol. Environ. Health 30:239-59